The Subcutaneous Implantable Cardioverter-Defibrillator: A Practical Review and Real-World Use and Application

• Main Authors: Mark E. Panna Jr, MD, FACC, FHRS, William M. Miles, MD, FACC, FHRS
• Format: Article
• Language: English
• Published: Compuscript 2016-02-01
• Series: Cardiovascular Innovations and Applications
• Subjects: subcutaneous implantable cardioverter-defibrillator; sudden cardiac death
• Online Access: http://www.ingentaconnect.com/content/cscript/cvia/2016/00000001/00000002/art00009
• ISSN: 2009-8618; 2009-8782

The subcutaneous implantable cardioverter-defibrillator (ICD) is a novel technology using a subcutaneous (extrathoracic) system for treatment of potential lethal ventricular arrhythmias. It avoids many of the risks of transvenous ICD implantation. It may be considered in patients having an ICD indication who do not have a pacing and/or cardiac resynchronization therapy indication, and who are unlikely to benefit from antitachycardia pacing therapy. We review patient selection, system components, the implantation technique, and screening considerations for subcutaneous ICD implantation. Its uses in specific patient populations, including children, patients with congenital heart disease, hypertrophic cardiomyopathy, or end-stage renal disease, and patients with preexisting pacemakers, are highlighted. Areas of future investigation are reviewed, including potential use with leadless pacing and magnetic resonance imaging.